ArticleFrontiers in pharmacology2026

A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges.

Zhifu You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.